I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 28% ± 9% | |
| glutamatergic neuron | 4 studies | 37% ± 10% | |
| interneuron | 3 studies | 32% ± 15% | |
| oligodendrocyte precursor cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 28% ± 9% | |
| glutamatergic neuron | 4 studies | 37% ± 10% | |
| interneuron | 3 studies | 32% ± 15% | |
| oligodendrocyte precursor cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 526.60 | 2627 / 2642 | 100% | 8.65 | 703 / 705 |
| prostate | 98% | 185.34 | 241 / 245 | 97% | 3.03 | 485 / 502 |
| thymus | 98% | 136.17 | 638 / 653 | 90% | 2.14 | 545 / 605 |
| ovary | 100% | 286.97 | 180 / 180 | 75% | 2.97 | 324 / 430 |
| kidney | 90% | 142.60 | 80 / 89 | 71% | 2.28 | 642 / 901 |
| uterus | 95% | 159.83 | 161 / 170 | 43% | 2.56 | 197 / 459 |
| lung | 61% | 72.36 | 351 / 578 | 59% | 2.05 | 686 / 1155 |
| adrenal gland | 72% | 68.52 | 185 / 258 | 44% | 0.93 | 101 / 230 |
| pancreas | 58% | 56.91 | 189 / 328 | 49% | 1.18 | 88 / 178 |
| esophagus | 64% | 80.36 | 925 / 1445 | 43% | 1.17 | 78 / 183 |
| bladder | 76% | 142.38 | 16 / 21 | 17% | 0.66 | 88 / 504 |
| skin | 39% | 32.62 | 710 / 1809 | 45% | 1.33 | 212 / 472 |
| breast | 57% | 58.22 | 261 / 459 | 21% | 0.96 | 239 / 1118 |
| blood vessel | 78% | 94.41 | 1039 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 62% | 80.24 | 596 / 966 | 9% | 0.22 | 48 / 527 |
| stomach | 39% | 45.27 | 140 / 359 | 14% | 0.47 | 41 / 286 |
| liver | 23% | 20.51 | 51 / 226 | 28% | 0.62 | 113 / 406 |
| adipose | 42% | 43.44 | 509 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 0.93 | 17 / 45 |
| heart | 27% | 28.81 | 236 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 16% | 0.24 | 13 / 80 |
| spleen | 12% | 8.45 | 29 / 241 | 0% | 0 | 0 / 0 |
| muscle | 12% | 10.23 | 96 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| peripheral blood | 3% | 1.98 | 25 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0000395 | Biological process | mRNA 5'-splice site recognition |
| GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
| GO_0000244 | Biological process | spliceosomal tri-snRNP complex assembly |
| GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0050733 | Molecular function | RS domain binding |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | SRSF12 |
| Protein name | Serine and arginine rich splicing factor 12 Serine/arginine-rich splicing factor 12 (35 kDa SR repressor protein) (SRrp35) (Splicing factor, arginine/serine-rich 13B) (Splicing factor, arginine/serine-rich 19) |
| Synonyms | SFRS13B SRRP35 SFRS19 |
| Description | FUNCTION: Splicing factor that seems to antagonize SR proteins in pre-mRNA splicing regulation. . |
| Accessions | E5RFT0 ENST00000452027.3 E5RJS0 Q8WXF0 ENST00000475068.1 ENST00000517387.1 |
